In vitro models for processes involved in intestinal absorption

• VAN ASPEREN J, VAN TELLINGEN O, BEIJNEN JH: The pharmacological role of P-glycoprotein in the intestinal epithelium. Pharmacol. Res. (1998) 37(6):429-435.
   PubMed Web of Science ®Google Scholar
• EDDERSHAW PJ, BERESFORD AP, BAYLISS MK: ADME/PK as part of a rational approach to drug discovery. Drug Disc. Today (2000) 5(9):409-414.
   PubMed Web of Science ®Google Scholar
• OPREA TI, DAVIS AM, TEAGUE SJ, LEESON PD: Is there a difference between leads and drugs? A historical perspective. J. Chem. Inf. Comput. Sci. (2001) 41(5):1308-1315.
   PubMedGoogle Scholar
• STONER CL, CLETON A, JOHNSON K et al.: Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery. Int. J. Pharm. (2004) 269(1):241-249.
   PubMedGoogle Scholar
• KERNS EH, DI L: Pharmaceutical profiling in drug discovery. Drug Disc. Today (2003) 8(7):316-323.
   PubMed Web of Science ®Google Scholar
• VAN DE WATERBEEMD H, LENNERNÄS H, ARTURSSON P: In vivo Permeability Studies in the Gastrointestinal Tract of Humans. In: Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability. Wiley-VCH, Weinheim, Germany (2003):155-188.
   Google Scholar
• GOODMAN LS, HARDMAN JG, LIMBIRD LE, GILMAN AG: Goodman & Gilman's the Pharmacological Basis of Therapeutics. McGraw-Hill, New York, USA (2001):18-24.
   Google Scholar
• KASSEL DB: Applications of high-throughput ADME in drug discovery. Curr. Opin. Chem. Biol. (2004) 8(3):339-345.
   PubMed Web of Science ®Google Scholar
• BERESFORD AP, SELICK HE, TARBIT MH: The emerging importance of predictive ADME simulation in drug discovery. Drug Disc. Today (2002) 7(2):109-116.
   PubMed Web of Science ®Google Scholar
• CORTI G, MAESTRELLI F, CIRRI M, ZERROUK N, MURA P: Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability. Eur. J. Pharm. Sci. (2006) 27(4):354-362.
   PubMed Web of Science ®Google Scholar
• BALIMANE PV, CHONG S: Cell culture-based models for intestinal permeability: a critique. Drug Disc. Today (2005) 10(5):335-343.
   PubMed Web of Science ®Google Scholar
• MARINO AM, YARDE M, PATEL H, CHONG S, BALIMANE PV: Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds. Int. J. Pharm. (2005) 297(1-2):235-241.
   PubMed Web of Science ®Google Scholar
• MIRET S, ABRAHAMSE L, DE GROENE EM: Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa. J. Biomol. Screen. (2004) 9(7):598-606.
   PubMed Web of Science ®Google Scholar
• RAEVSKY OA: Physicochemical descriptors in property-based drug design. Mini. Rev. Med. Chem. (2004) 4(10):1041-1052.
   PubMed Web of Science ®Google Scholar
• KERNS EH, DI L: Physicochemical profiling: overview of the screens. Drug Disc. Today Technol. (2004) 1(4):343-348.
   PubMedGoogle Scholar
• VAN DE WATERBEEMD H, LENNERNÄS H, ARTURSSON P: High-throughput Measurement of logD and pKa. In: Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability. Wiley-VCH, Weinheim, Germany (2003):21-45.
   Google Scholar
• BUCHWALD P, BODOR N: Octanol-water partition: searching for predictive models. Curr. Med. Chem. (1998) 5(5):353-380.
   PubMed Web of Science ®Google Scholar
• KRISTL A, PECAR S, KMETEC V: Are calculated log P values for some guanine derivatives by different computer programs reliable? Int. J. Pharm. (1999) 181(2):219-226.
   PubMedGoogle Scholar
• LIPINSKI CA, LOMBARDO F, DOMINY BW, FEENEY PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. (1997) 23(1-3):3-25.
   Web of Science ®Google Scholar
• HENDRIKSEN BA, FELIX MV, BOLGER MB: The composite solubility versus pH profile and its role in intestinal absorption prediction. AAPS PharmSci. (2003) 5(1):E4.
   PubMedGoogle Scholar
• BHATTACHAR SN, DESCHENES LA, WESLEY JA: Solubility: it's not just for physical chemists. Drug Disc. Today (2006) 11(21-22):1012-1018.
   PubMed Web of Science ®Google Scholar
• DI L, KERNS EH: Biological assay challenges from compound solubility: strategies for bioassay optimization. Drug Disc. Today (2006) 11(9-10):446-451.
   PubMed Web of Science ®Google Scholar
• WASSVIK CM, HOLMEN AG, BERGSTROM CA, ZAMORA I, ARTURSSON P: Contribution of solid-state properties to the aqueous solubility of drugs. Eur. J. Pharm. Sci. (2006) 29(3-4):294-305.
   PubMed Web of Science ®Google Scholar
• NIGSCH F, BENDER A, VAN BUUREN B, TISSEN J, NIGSCH E, MITCHELL JBO: Melting point prediction employing k-nearest neighbor algorithms and genetic parameter optimization. J. Chem. Inf. Model (2006) 46(6):2412-2422.
   PubMed Web of Science ®Google Scholar
• BERGSTROM CA, LUTHMAN K, ARTURSSON P: Accuracy of calculated pH-dependent aqueous drug solubility. Eur. J. Pharm. Sci. (2004) 22(5):387-398.
   PubMed Web of Science ®Google Scholar
• HORTER D, DRESSMAN JB: Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. (2001) 46(1-3):75-87.
   PubMed Web of Science ®Google Scholar
• MORISSETTE SL, ALMARSSON O, PETERSON ML et al.: High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv. Drug Deliv. Rev. (2004) 56(3):275-300.
   PubMed Web of Science ®Google Scholar
• YALKOWSKY SH, BANERJEE S: Aqueous Solubility: Methods of Estimation for Organic Compounds. Marcel Dekker, New York, USA (1992).
   Google Scholar
• PAN L, HO Q, TSUTSUI K, TAKAHASHI L: Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility. J. Pharm. Sci. (2001) 90(4):521-529.
   PubMed Web of Science ®Google Scholar
• BEVAN CD, LLOYD RS: A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal. Chem. (2000) 72(8):1781-1787.
   PubMed Web of Science ®Google Scholar
• STUART M, BOX K: Chasing equilibrium: measuring the intrinsic solubility of weak acids and bases. Anal. Chem. (2005) 77(4):983-990.
   PubMed Web of Science ®Google Scholar
• LLINAS A, BURLEY JC, BOX KJ, GLEN RC, GOODMAN JM: Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms. J. Med. Chem. (2007) 50(5):979-983.
   PubMed Web of Science ®Google Scholar
• LLINAS A, BOX KJ, BURLEY JC, GLEN RC, GOODMAN JM: A new method for the reproducible generation of polymorphs: two forms of sulindac with very different solubilities. J. Appl. Crystallogr. (2007) 40:379-381.
   Web of Science ®Google Scholar
• MALKIA A, MURTOMAKI L, URTTI A, KONTTURI K: Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties. Eur. J. Pharm. Sci. (2004) 23(1):13-47.
   PubMed Web of Science ®Google Scholar
• WIEDMANN TS, KAMEL L: Examination of the solubilization of drugs by bile salt micelles. J. Pharm. Sci. (2002) 91(8):1743-1764.
   PubMed Web of Science ®Google Scholar
• INGELS FM, AUGUSTIJNS PF: Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2. J. Pharm. Sci. (2003) 92(8):1545-1558.
   PubMed Web of Science ®Google Scholar
• VAN DE WATERBEEMD H, LENNERNÄS H, ARTURSSON P: Aqeous Solubility in Discovery, Chemistry, and Assay Changes. In: Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability. Wiley-VCH, Weinheim, Germany (2003):215-231.
   Google Scholar
• DOKOUMETZIDIS A, MACHERAS P: A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System. Int. J. Pharm. (2006) 321(1-2):1-11.
   PubMed Web of Science ®Google Scholar
• DELANEY JS: Predicting aqueous solubility from structure. Drug Disc. Today (2005) 10(4):289-295.
   PubMed Web of Science ®Google Scholar
• GOODWIN JJ: Rationale and benefit of using high throughput solubility screens in drug discovery. Drug Disc. Today Technol. (2006) 3(1):67-71.
   PubMedGoogle Scholar
• JOHNSON SR, ZHENG WF: Recent progress in the computational prediction of aqueous solubility and absorption. AAPS J. (2006) 8(1):E27-E40.
   PubMed Web of Science ®Google Scholar
• AVDEEF A: Physicochemical profiling (solubility, permeability and charge state). Curr. Top. Med. Chem. (2001) 1(4):277-351.
   PubMedGoogle Scholar
• CHAN ECY, TAN WL, HO PC, FANG LJ: Modeling Caco-2 permeability of drugs using immobilized artificial membrane chromatography and physicochemical descriptors. J. Chromatogr. A (2005) 1072(2):159-168.
   PubMed Web of Science ®Google Scholar
• DECONINCK E, ATES H, CALLEBAUT N, VAN GYSEGHEM E, VANDER HEYDEN Y: Evaluation of chromatographic descriptors for the prediction of gastro-intestinal absorption of drugs. J. Chromatogr. A (2007) 1138(1-2):190-202.
   PubMed Web of Science ®Google Scholar
• TAILLARDAT-BERTSCHINGER A, MARTINET CA, CARRUPT PA et al.: Molecular factors influencing retention on immobilized artifical membranes (IAM) compared to partitioning in liposomes and n-octanol. Pharm. Res. (2002) 19(6):729-737.
   PubMed Web of Science ®Google Scholar
• GENTY M, GONZALEZ G, CLERE C, DESANGLE-GOUTY V, LEGENDRE JY: Determination of the passive absorption through the rat intestine using chromatographic indices and molar volume. Eur. J. Pharm. Sci. (2001) 12(3):223-229.
   PubMed Web of Science ®Google Scholar
• STEWART BH, CHUNG FY, TAIT B, BLANKLEY CJ, CHAN OH: Hydrophobicity of HIV protease inhibitors by immobilized artificial membrane chromatography: application and significance to drug transport. Pharm. Res. (1998) 15(9):1401-1406.
   PubMed Web of Science ®Google Scholar
• AVDEEF A: Absorption and Drug Development: Solubility, Permeability and Charge State. Wiley-Interscience, Hoboken NJ, USA (2003).
   Google Scholar
• KARLSSON J, ARTURSSON P: A method for the determination of cellular permeability coefficients and aqueous boundary-layer thickness in monolayers of intestinal epithelial (Caco-2) cells grown in permeable filter chambers. Int. J. Pharm. (1991) 71(1-2):55-64.
   Web of Science ®Google Scholar
• KANSY M, SENNER F, GUBERNATOR K: Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J. Med. Chem. (1998) 41(7):1007-1010.
   PubMed Web of Science ®Google Scholar
• KANSY M, AVDEEF A, FISCHER H: Advances in screening for membrane permeability: high-resolution PAMPA for medicinal chemists. Drug Disc. Today Technol. (2004) 1(4):349-355.
   PubMedGoogle Scholar
• SEO PR, TEKSIN ZS, KAO JP, POLLI JE: Lipid composition effect on permeability across PAMPA. Eur. J. Pharm. Sci. (2006) 29(3-4):259-268.
   PubMed Web of Science ®Google Scholar
• CORTI G, MAESTRELLI F, CIRRI M, FURLANETTO S, MURA P: Development and evaluation of an in vitro method for prediction of human drug absorption I. Assessment of artificial membrane composition. Eur. J. Pharm. Sci. (2006) 27(4):346-353.
   PubMed Web of Science ®Google Scholar
• AVDEEF A, ARTURSSON P, NEUHOFF S, LAZOROVA L, GRASJO J, TAVELIN S: Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA pK(a)(flux) method. Eur. J. Pharm. Sci. (2005) 24(4):333-349.
   PubMed Web of Science ®Google Scholar
• VAN DE WATERBEEMD H, LENNERNÄS H, ARTURSSON P: High-throughput Measurement of Permeability Profiles. In: Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability. Wiley-VCH, Weinheim, Germany (2003):46-71.
   Google Scholar
• MELCHIOR DL, MAKRIYANNIS A: Application of fluorosome stopped-flow spectrophotometry to monitor the entry of molecules into lipid bilayers. Biotechnol. Tech. (1997) 11(12):885-888.
   Google Scholar
• FIX M, MELCHIOR DL: The Fluorosome technique for investigating membrane on- and off-loading of drugs by β-CD and sonicated SUV. FEBS Lett. (2002) 516(1-3):109-112.
   PubMed Web of Science ®Google Scholar
• LOFAS S, MALMQVIST M, RONNBERG I, STENBERG E, LIEDBERG B, LUNDSTROM I: Bioanalysis with surface-plasmon resonance. Sens. Actuators B Chem. (1991) 5(1-4):79-84.
   Web of Science ®Google Scholar
• LOFAS S: Optimizing the hit-to-lead process using SPR analysis. Assay Drug Devel. Techn. (2004) 2(4):407-415.
   PubMed Web of Science ®Google Scholar
• FROSTELL-KARLSSON A, WIDEGREN H, GREEN CE et al.: Biosensor analysis of the interaction between drug compounds and liposomes of different properties; a two-dimensional characterization tool for estimation of membrane absorption. J. Pharm. Sci. (2005) 94(1):25-37.
   PubMed Web of Science ®Google Scholar
• JONSSON U, FAGERSTAM L, IVARSSON B et al.: Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques (1991) 11(5):620-627.
   PubMed Web of Science ®Google Scholar
• ABDICHE YN, MYSZKA DG: Probing the mechanism of drug/lipid membrane interactions using Biacore. Anal. Biochem. (2004) 328(2):233-243.
   PubMed Web of Science ®Google Scholar
• FOGH J, WRIGHT WC, LOVELESS JD: Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. (1977) 58(2):209-214.
   PubMed Web of Science ®Google Scholar
• ARTURSSON P, PALM K, LUTHMAN K: Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. (2001) 46(1-3):27-43.
   PubMed Web of Science ®Google Scholar
• UNGELL A-L B: Caco-2 replace or refine? Drug Disc. Today Technol. (2004) 1(4):423-430.
   PubMedGoogle Scholar
• PFRUNDER A, GUTMANN H, BEGLINGER C, DREWE J: Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J. Pharm. Pharmacol. (2003) 55(1):59-66.
   PubMed Web of Science ®Google Scholar
• BRISKE-ANDERSON MJ, FINLEY JW, NEWMAN SM: The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc. Soc. Exp. Biol. Med. (1997) 214(3):248-257.
   PubMed Web of Science ®Google Scholar
• ZUCCO F, BATTO AF, BISES G et al.: An inter-laboratory study to evaluate the effects of medium composition on the differentiation and barrier function of Caco-2 cell lines. Altern. Lab. Anim. (2005) 33(6):603-618.
   PubMed Web of Science ®Google Scholar
• BRAUN A, HAMMERLE S, SUDA K, et al.: Cell cultures as tools in biopharmacy. Eur. J. Pharm. Sci. (2000) 11(Suppl. 2):S51-S60.
   PubMed Web of Science ®Google Scholar
• PONTIER C, PACHOT J, BOTHAM R, LENFANT B, ARNAUD P: HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. J. Pharm. Sci. (2001) 90(10):1608-1619.
   PubMed Web of Science ®Google Scholar
• TAVELIN S, MILOVIC V, OCKLIND G, OLSSON S, ARTURSSON P: A conditionally immortalized epithelial cell line for studies of intestinal drug transport. J. Pharmacol. Exp. Ther. (1999) 290(3):1212-1221.
   PubMed Web of Science ®Google Scholar
• MATSSON P, BERGSTROM CAS, NAGAHARA N, TAVELIN S, NORINDER U, ARTURSSON P: Exploring the role of different drug transport routes in permeability screening. J. Med. Chem. (2005) 48(2):604-613.
   PubMed Web of Science ®Google Scholar
• CARRIERE V, LESUFFLEUR T, BARBAT A et al.: Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7. FEBS Lett. (1994) 355(3):247-250.
   PubMed Web of Science ®Google Scholar
• PUTNAM WS, RAMANATHAN S, PAN L, TAKAHASHI LH, BENET LZ: Functional characterization of monocarboxylic acid, large neutral amino acid, bile acid and peptide transporters, and P-glycoprotein in MDCK and Caco-2 cells. J. Pharm. Sci. (2002) 91(12):2622-2635.
   PubMed Web of Science ®Google Scholar
• PUTNAM WS, PAN L, TSUTSUI K, TAKAHASHI L, BENET LZ: Comparison of bidirectional cephalexin transport across MDCK and Caco-2 cell monolayers: interactions with peptide transporters. Pharm. Res. (2002) 19(1):27-33.
   PubMed Web of Science ®Google Scholar
• JIN F, WELCH R, GLAHN R: Moving toward a more physiological model: application of mucin to refine the in vitro digestion/Caco-2 cell culture system. J. Agric. Food Chem. (2006) 54(23):8962-8967.
   PubMed Web of Science ®Google Scholar
• SAI Y, TSUJI A: Transporter-mediated drug delivery: recent progress and experimental approaches. Drug Discov. Today (2004) 9(16):712-720.
   PubMed Web of Science ®Google Scholar
• KIM RB: Transporters and drug discovery: why, when and how. Mol. Pharm. (2006) 3(1):26-32.
   PubMed Web of Science ®Google Scholar
• BRAND W, SCHUTTE ME, WILLIAMSON G et al.: Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed. Pharmacother. (2006) 60(9):508-519.
   PubMed Web of Science ®Google Scholar
• ENGLUND G, RORSMAN F, RONNBLOM A et al.: Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur. J. Pharm. Sci. (2006) 29(3-4):269-277.
   PubMed Web of Science ®Google Scholar
• TERADA T, INUI K: Gene expression and regulation of drug transporters in the intestine and kidney. Biochem. Pharmacol. (2007) 73(3):440-449.
   PubMed Web of Science ®Google Scholar
• VAN ITALLIE CM, ANDERSON JM: The molecular physiology of tight junction pores. Physiology (Bethesda) (2004) 19:331-338.
   PubMed Web of Science ®Google Scholar
• SCHNEEBERGER EE, LYNCH RD: The tight junction: a multifunctional complex. Am. J. Physiol. Cell Physiol. (2004) 286(6):C1213-C1228.
   PubMed Web of Science ®Google Scholar
• POWELL DW: Barrier function of epithelia. Am. J. Physiol. (1981) 241(4):G275-G288.
   PubMed Web of Science ®Google Scholar
• WATSON CJ, ROWLAND M, WARHURST G: Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers. Am. J. Physiol. Cell Physiol. (2001) 281(2):C388-C397.
   PubMed Web of Science ®Google Scholar
• ARRIETA MC, BISTRITZ L, MEDDINGS JB: Alterations in intestinal permeability. Gut (2006) 55(10):1512-1520.
   PubMed Web of Science ®Google Scholar
• MCKAY DM: Good bug, bad bug: in the case of enteric inflammatory disease does the epithelium decide? Mem. Inst. Oswaldo Cruz. (2005) 100(Suppl. 1):205-210.
   PubMedGoogle Scholar
• KNIPP GT, HO NF, BARSUHN CL, BORCHARDT RT: Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. J. Pharm. Sci. (1997) 86(10):1105-1110.
   PubMed Web of Science ®Google Scholar
• MENEZ C, BUYSE M, CHACUN H, FARINOTTI R, BARRATT G: Modulation of intestinal barrier properties by miltefosine. Biochem. Pharmacol. (2006) 71(4):486-496.
   PubMed Web of Science ®Google Scholar
• SEKI T, KANBAYASHI H, NAGAO T, CHONO S, TABATA Y, MORIMOTO K: Effect of cationized gelatins on the paracellular transport of drugs through Caco-2 cell monolayers. J. Pharm. Sci. (2006) 95(6):1393-1401.
   PubMed Web of Science ®Google Scholar
• TSUTSUMI K, LI SK, GHANEM AH, HO NF, HIGUCHI WI: A systematic examination of the in vitro using chamber and the in situ single-pass perfusion model systems in rat ileum permeation of model solutes. J. Pharm. Sci. (2003) 92(2):344-359.
   PubMed Web of Science ®Google Scholar
• GRASS GM, SINKO PJ: Physiologically-based pharmacokinetic simulation modelling. Adv. Drug Deliv. Rev. (2002) 54(3):433-451.
   PubMed Web of Science ®Google Scholar
• TIMCHALK C: Comparative inter-species pharmacokinetics of phenoxyacetic acid herbicides and related organic acids. evidence that the dog is not a relevant species for evaluation of human health risk. Toxicology (2004) 200(1):1-19.
   PubMed Web of Science ®Google Scholar
• PRUEKSARITANONT T, LIN JH, BAILLIE TA: Complicating factors in safety testing of drug metabolites: kinetic differences between generated and preformed metabolites. Toxicol. Appl. Pharmacol. (2006) 217(2):143-152.
   PubMed Web of Science ®Google Scholar
• KERNS EH, DI L, PETUSKY S, FARRIS M, LEY R, JUPP P: Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery. J. Pharm. Sci. (2004) 93(6):1440-1453.
   PubMed Web of Science ®Google Scholar
• GARRETT DA, FAILLA ML, SARAMA RJ: Development of an in vitro digestion method to assess carotenoid bioavailability from meals. J. Agric. Food Chem. (1999) 47(10):4301-4309.
   PubMed Web of Science ®Google Scholar
• LIU CS, GLAHN RP, LIU RH: Assessment of carotenoid bioavailability of whole foods using a Caco-2 cell culture model coupled with an in vitro digestion. J. Agric. Food Chem. (2004) 52(13):4330-4337.
   PubMed Web of Science ®Google Scholar
• GLAHN RP, CHENG Z, WELCH RM, GREGORIO GB: Comparison of iron bioavailability from 15 rice genotypes: studies using an in vitro digestion/caco-2 cell culture model. J. Agric. Food Chem. (2002) 50(12):3586-3591.
   PubMed Web of Science ®Google Scholar
• ETCHEVERRY P, WALLINGFORD JC, MILLER DD, GLAHN RP: The effect of calcium salts, ascorbic acid and peptic pH on calcium, zinc and iron bioavailabilities from fortified human milk using an in vitro digestion/Caco-2 cell model. Int. J. Vitam. Nutr. Res. (2005) 75(3):171-178.
   PubMed Web of Science ®Google Scholar
• BHAGAVAN HN, CHOPRA RK, CRAFT NE, CHITCHUMROONCHOKCHAI C, FAILLA ML: Assessment of coenzyme Q10 absorption using an in vitro digestion–Caco-2 cell model. Int. J. Pharm. (2007) 333(1-2):112-117.
   PubMed Web of Science ®Google Scholar
• FERRUZZI MG, LUMPKIN JL, SCHWARTZ SJ, FAILLA M: Digestive Stability, micellarization, and uptake of beta-carotene isomers by Caco-2 human intestinal cells. J. Agric. Food Chem. (2006) 54(7):2780-2785.
   PubMed Web of Science ®Google Scholar
• MORENO FJ: Gastrointestinal digestion of food allergens: effect on their allergenicity. Biomed. Pharmacother. (2007) 61(1):50-60.
   PubMed Web of Science ®Google Scholar
• TROPSHA A, GRAMATICA P, GOMBAR VK: The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb. Sci. (2003) 22(1):69-77.
   Google Scholar
• BAUMANN K, STIEFL N: Validation tools for variable subset regression. J. Comput. Aided Mol. Design (2004) 18(7):549-562.
   PubMed Web of Science ®Google Scholar
• STAHL M, GUBA W, KANSY M: Integrating molecular design resources within modern drug discovery research: the Roche experience. Drug Disc. Today (2006) 11(7-8):326-333.
   PubMed Web of Science ®Google Scholar
• VIGANO C, MANCIU L, RUYSSCHAERT JM: Structure, orientation, and conformational changes in transmembrane domains of multidrug transporters. Acc. Chem. Res. (2005) 38(2):117-126.
   PubMed Web of Science ®Google Scholar
• CONGREVE M, MURRAY CW, BLUNDELL TL: Structural biology and drug discovery. Drug Disc. Today (2005) 10(13):895-907.
   PubMed Web of Science ®Google Scholar
• CHANG C, RAY A, SWAAN P: In silico strategies for modeling membrane transporter function. Drug Disc. Today (2005) 10(9):663-671.
   PubMed Web of Science ®Google Scholar
• CHANG C, EKINS S, BAHADDURI P, SWAAN PW: Pharmacophore-based discovery of ligands for drug transporters. Adv. Drug Deliv. Rev. (2006) 58(12-13):1431-1450.
   PubMed Web of Science ®Google Scholar
• SINZ MW, KIM S: Stem cells, immortalized cells and primary cells in ADMET assays. Drug Disc. Today Technol. (2006) 3(1):79-85.
   PubMedGoogle Scholar
• LI AP, BODE C, SAKAI Y: A novel in vitro system, the integrated discrete multiple organ cell culture (IdMOC) system, for the evaluation of human drug toxicity: comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells. Chem. Biol. Interact. (2004) 150(1):129-136.
   PubMed Web of Science ®Google Scholar
• BAJORATH J: Integration of virtual and high-throughput screening. Nat. Rev. Drug Disc. (2002) 1(11):882-894.
   PubMed Web of Science ®Google Scholar
• VAN DE WATERBEEMD H, GIFFORD E: ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov. (2003) 2(3):192-204.
   PubMed Web of Science ®Google Scholar

Websites

• http://www.cheqsol.com/ CheqSol (Accessed 14/02/2007).
   Google Scholar
• http://www.sirius-analytical.com/ Sirius Analytical Instruments, Ltd (Accessed 14/02/2007).
   Google Scholar
• http://www.glsynthesis.com/
   Google Scholar
• http://www.biacore.com/lifesciences/technology/introduction/Flow_cells/index.html Biacore (Accessed 25/04/2007).
   Google Scholar
• http://www.gene.ucl.ac.uk/nomenclature/genefamily.html Solute carrier transporters (Accessed 25/04/2007).
   Google Scholar
• http://www.gene.ucl.ac.uk/nomenclature/genefamily/abc.php ATP-binding cassette transporters (Accessed 25/04/2007).
   Google Scholar